A 3-year-old child from rural Maharashtra presents with failure to thrive, developmental delay, and recurrent infections. Serum lactate is elevated at 8 mmol/L (normal <2), and pyruvate is 0.5 mmol/L. Muscle biopsy shows ragged-red fibres on Gomori trichrome stain. Which investigation is most appropriate to confirm the suspected mitochondrial cytopathy involving the electron transport chain?

Explanation

## Diagnosis of Mitochondrial Electron Transport Chain Disorders ### Clinical Presentation The constellation of failure to thrive, developmental delay, elevated serum lactate with normal/low pyruvate, and ragged-red fibres on muscle biopsy is pathognomonic for mitochondrial cytopathy — specifically a defect in the electron transport chain (ETC). **Key Point:** Ragged-red fibres indicate abnormal mitochondrial proliferation and are the hallmark histological finding in mitochondrial disorders. ### Investigation Hierarchy for ETC Defects | Investigation | Role | Diagnostic Yield | |---|---|---| | **Mitochondrial DNA sequencing** | Identifies point mutations (m.3243A>G in MELAS, m.8344A>G in MERRF) | High for genetic confirmation | | **Respiratory chain enzyme assay** | Measures activities of Complex I, II, III, IV, V in muscle mitochondria | Gold standard for functional assessment | | **Serum/CSF lactate** | Elevated in anaerobic metabolism; non-specific | Supportive only | | **Serum carnitine** | Relevant in fatty acid oxidation defects, not ETC | Wrong metabolic pathway | | **Amino acid/organic acid profiles** | Useful in aminoacidopathies, not mitochondrial ETC | Different pathophysiology | ### Why Mitochondrial DNA Sequencing + Respiratory Chain Enzyme Assay? **High-Yield:** The combination provides both genetic diagnosis (mutation identification) and functional confirmation (enzyme deficiency). Muscle biopsy homogenate is the tissue of choice because: 1. Ragged-red fibres are already present (high mitochondrial density) 2. ETC enzyme activities are measurable in fresh or frozen muscle 3. Genetic mutations in mtDNA are tissue-specific and enriched in muscle **Clinical Pearl:** A single elevated serum lactate is insufficient; you need tissue-level evidence of ETC dysfunction. Respiratory chain enzyme assay showing reduced activity of one or more complexes (I, III, IV most common) confirms the diagnosis. **Mnemonic: MELAS & MERRF** — the two most common mtDNA-associated ETC disorders: - **MELAS** (Mitochondrial Encephalomyopathy, Lactic Acidosis, Stroke-like episodes): m.3243A>G mutation - **MERRF** (Myoclonic Epilepsy with Ragged-Red Fibres): m.8344A>G mutation ### Why Not the Other Options? - **Serum carnitine:** Relevant in primary carnitine deficiency or fatty acid oxidation disorders (CPT I/II deficiency), not ETC defects. Lactate elevation is not due to carnitine insufficiency here. - **Plasma amino acids/urine organic acids:** These are primary tools for aminoacidopathies (e.g., maple syrup urine disease, organic acidemias). ETC defects do not produce characteristic amino acid or organic acid patterns. - **CSF lactate/pyruvate:** While CSF lactate may be elevated in severe mitochondrial disease, it is neither specific nor diagnostic. It cannot differentiate between ETC defects and other causes of lactic acidosis. [cite:Robbins 10e Ch 7]